Shiro Yanagi

Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injury

Minoru Yoshiyama, Shokei Kim, Hiroyuki Yamagishi et al. · American Heart Journal · 1994 · 91 citations

Inflammation, Thrombosis, Cardioprotective Effect +12

Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal coronary angioplasty

Akira Tahara, Masakazu Kohno, Shiro Yanagi et al. · Metabolism · 1991 · 71 citations

Percutaneous Coronary Intervention, Vascular Disease, Cardiovascular Disease +10

A Prospective, Multicenter, Randomized Trial to Assess Efficacy of Pioglitazone on In-Stent Neointimal Suppression in Type 2 Diabetes

Tsutomu Takagi, Hiroyuki Okura, Yoshiki Kobayashi et al. · JACC: Cardiovascular Interventions · 2009 · 64 citations

Metabolic Syndrome, In-stent Neointimal Suppression, Diabetes Management +12

Estimation of infarct size using serum troponin T concentration in patients with acute myocardial infarction.

Takashi Omura, Masakazu Teragaki, Tomoko Tani et al. · Japanese Circulation Journal · 1993 · 38 citations · Full text

[Evaluation of coronary flow reserve using Doppler guide wire in patients with ampulla cardiomyopathy: three case reports].

Shiro Yanagi, Keiji Nagae, Kaoru Yoshida et al. · PubMed · 2002 · 27 citations